The benefits of excess EPCR
Authors:
- 1 July 2005
- journal article
- editorial
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 3 (7) , 1349-1350
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxinJournal of Thrombosis and Haemostasis, 2005
- A cardioprotective role for the endothelial protein C receptor in lipopolysaccharide-induced endotoxemia in the mouseBlood, 2005
- Activated protein C variants with normal cytoprotective but reduced anticoagulant activityBlood, 2004
- Thrombomodulin-Protein C-EPCR SystemArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosisBlood, 2004
- Thrombin Activatable Fibrinolysis Inhibitor (TAFI) at the Interface between Coagulation and FibrinolysisPathophysiology of Haemostasis and Thrombosis, 2003
- The Protein C PathwayChest, 2003
- Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C PathwayScience, 2002
- Efficacy and Safety of Recombinant Human Activated Protein C for Severe SepsisNew England Journal of Medicine, 2001
- Human Protein C Receptor Is Present Primarily on Endothelium of Large Blood VesselsCirculation, 1997